BGI announced that Tadataka (Tachi) Yamada, M.D., has joined BGI to serve as its Chairman of the Scientific Advisory Board (SAB). Dr. Yamada has extensive experience and insight in medical healthcare. He currently is the Chairman and Co-founder at Outpost Medicine, and a Venture Partner at Frazier Healthcare Partners.

BGI will soon launch the International Community of Precision Medicine to accelerate progress and 30 hospitals in China with a total of 50 million annual outpatients have already signed on. As Chairman of SAB, Dr. Yamada will devote efforts to provide professional advice based on his rich experience and insights in the field.